Patents by Inventor Ángel Rumbero Sánchez

Ángel Rumbero Sánchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11981878
    Abstract: The present invention relates to a method for municipal solid waste (MSW) reclamation in a continuous or discontinuous process first for converting said waste into organic biomass and subsequently extracting and recovering the most chemical compounds contained in said biomass possible, such as triglycerides, sugars and proteins. Therefore, the invention is comprised in the field of recycling, transforming solid waste into reusable solids and biofuels.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: May 14, 2024
    Assignee: ECONWARD TECH.
    Inventors: Rubén García Cano, Jorge Crespo Lobo, Ángel Rumbero Sanchez, Nuria Cano Adamuz, Alejandro Villacampa Sanagustín, Oscar Orozco González
  • Publication number: 20230348365
    Abstract: The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.
    Type: Application
    Filed: January 18, 2023
    Publication date: November 2, 2023
    Inventors: Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
  • Patent number: 11584710
    Abstract: The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: February 21, 2023
    Assignee: HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁG
    Inventors: Alfredo Hernández Cabanillas, Santiago Maderuelo Corral, Montserrat Ortega Doménech, Diego Fernando Rosero Valencia, Ángel Rumbero Sánchez, Victor Tena Pérez
  • Publication number: 20220364017
    Abstract: The present invention relates to a method for municipal solid waste (MSW) reclamation in a continuous or discontinuous process first for converting said waste into organic biomass and subsequently extracting and recovering the most chemical compounds contained in said biomass possible, such as triglycerides, sugars and proteins. Therefore, the invention is comprised in the field of recycling, transforming solid waste into reusable solids and biofuels.
    Type: Application
    Filed: June 21, 2019
    Publication date: November 17, 2022
    Inventors: Rubén GARCÍA CANO, Jorge CRESPO LOBO, Ángel RUMBERO SANCHEZ, Nuria CANO ALAMUZ, Alejandro VILLACAMPA SANAGUSTÍN, Oscar OROZCO GONZÁLEZ
  • Publication number: 20220315544
    Abstract: The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt, stereoisomer or solvate thereof for use in the prevention and/or treatment of a pathology associated with proinflammatory conditions, a disease associated with oxidative stress or production of reactive oxygen species or a skin pigmentation disorder. In addition, the invention also relates to a cosmetic method for preventing and/or treating skin aging, irradiated skin or for skin-whitening comprising administering a compound of formula (I) or a cosmetically acceptable salt, stereoisomer or solvate thereof. In addition, the invention relates to a method of inhibition of enzymatic browning in food or beverage comprising contacting said food or beverage with a compound of formula (I) or a salt, stereoisomer or solvate thereof under conditions sufficient to inhibit enzymatic browning of said food or beverage.
    Type: Application
    Filed: June 1, 2020
    Publication date: October 6, 2022
    Inventors: ALFREDO HERNÁNDEZ CABANILLAS, SANTIAGO MADERUELO CORRAL, MONTSERRAT ORTEGA DOMÉNECH, DIEGO FERNANDO ROSERO VALENCIA, ÁNGEL RUMBERO SÁNCHEZ, VICTOR TENA PÉREZ, LUIS NÉSTOR APAZA TICONA
  • Patent number: 11241440
    Abstract: The invention relates to the use of 1-(4,6-dipentyl-5,6-dihydro-2H-1,2,3-oxadiazin-2-yl)-3-hydroxypropan-1-one in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compound of formula (I) of the invention, said process comprising the steps of cultivating a strain of Dolichospermum sp in an aqueous nutrient medium with assimilable carbon and nitrogen sources and salts, under controlled aerobic conditions, and then recovering the compound of general formula (I) from the culture broth.
    Type: Grant
    Filed: December 29, 2016
    Date of Patent: February 8, 2022
    Assignee: Valoralia | Mas D, SL
    Inventors: Ana María González Fuente, Alfredo Hernández Cabanillas, Santiago Maderuelo Corral, Montserrat Ortega Doménech, Diego Fernando Rosero Valencia, Ángel Rumbero Sánchez, Victor Tena Pérez
  • Publication number: 20210155578
    Abstract: The invention relates to hydrazide compounds and their use in medicine, particularly in treating and/or preventing infections caused by a fungus.
    Type: Application
    Filed: July 31, 2018
    Publication date: May 27, 2021
    Inventors: Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
  • Patent number: 11008295
    Abstract: The invention relates to novel compounds and their use in medicine, particularly in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compounds of the invention.
    Type: Grant
    Filed: April 25, 2018
    Date of Patent: May 18, 2021
    Assignee: HORITZONTS TECNOLOGICS HUNGARY KORLÁTOLT FELELOSSÉGU TÁRSASÁG
    Inventors: Alfredo Hernández Cabanillas, Santiago Maderuelo Corral, Montserrat Ortega Doménech, Diego Fernando Rosero Valencia, Ángel Rumbero Sánchez, Victor Tena Pérez
  • Publication number: 20200316082
    Abstract: The invention relates to the use of 1-(4,6-dipentyl-5,6-dihydro-2H-1,2,3-oxadiazin-2-yl)-3-hydroxypropan-1-one in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compound of formula (I) of the invention, said process comprising the steps of cultivating a strain of Dolichospermum sp in an aqueous nutrient medium with assimilable carbon and nitrogen sources and salts, under controlled aerobic conditions, and then recovering the compound of general formula (I) from the culture broth.
    Type: Application
    Filed: December 29, 2016
    Publication date: October 8, 2020
    Inventors: Ana María GONZÁLEZ FUENTE, Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
  • Publication number: 20200190044
    Abstract: The invention relates to novel compounds and their use in medicine, particularly in treating and/or preventing infections caused by a bacterium, fungus or virus or in treating and/or preventing cancer. Additionally, the invention relates to a process for obtaining the compounds of the invention.
    Type: Application
    Filed: April 25, 2018
    Publication date: June 18, 2020
    Inventors: Alfredo HERNÁNDEZ CABANILLAS, Santiago MADERUELO CORRAL, Montserrat ORTEGA DOMÉNECH, Diego Fernando ROSERO VALENCIA, Ángel RUMBERO SÁNCHEZ, Victor TENA PÉREZ
  • Publication number: 20140309295
    Abstract: The present invention describes a compound of formula (I) its hydroxy acid form, the pharmaceutically acceptable salts of said hydroxy acid and pharmaceutically acceptable prodrugs and solvates of the compound and of its hydroxy acid form and, in particular, said compound, its hydroxy acid form, salts, etc. for its use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with undesired oxidation, age-associated pathological processes and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases such as atherosclerosis, atrial fibrillation, dyslipemia, hypercholesterolemia, hyperlipidemia, and hypertriglyceridemia, or fungal or viral infections.
    Type: Application
    Filed: June 25, 2014
    Publication date: October 16, 2014
    Inventors: Javier Santos BURGOS MUÑOZ, José Luis ADRIO FONDEVILA, Maria del Carmen RAMOS MARTÍN, Saleta SIERRA ÁVILA, Juan Maria ALFARO SÁNCHEZ, Carlos RAMÍREZ MORENO, Sonia CAMPOY GARCIA, Javier VELASCO ALVAREZ, Ángel RUMBERO SÁNCHEZ
  • Publication number: 20120095091
    Abstract: The present invention describes a compound of formula (I) its hydroxy acid form, the pharmaceutically acceptable salts of said hydroxy acid and pharmaceutically acceptable prodrugs and solvates of the compound and of its hydroxy acid form and, in particular, said compound, its hydroxy acid form, salts, etc. for its use in the prevention of: neurodegenerative diseases, cognitive deterioration, diseases associated with undesired oxidation, age-associated pathological processes and progeria, epilepsy, epileptic seizures and convulsions, cardiovascular diseases such as atherosclerosis, atrial fibrillation, dyslipemia, hypercholesterolemia, hyperlipidemia, and hypertriglyceridemia, or fungal or viral infections.
    Type: Application
    Filed: April 16, 2010
    Publication date: April 19, 2012
    Applicant: Neuron Biopharma S.A
    Inventors: Javier Santos Burgos Muñoz, José Luis Adrio Fondevila, Maria del Carmen Ramos Martín, Saleta Sierra Ávila, Juan María Alfaro Sánchez, Carlos Ramírez Moreno, Sonia Campoy García, Javier Velasco Alvarez, Ángel Rumbero Sánchez
  • Publication number: 20110319484
    Abstract: The invention describes the use of (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl-1-naphthalenyl propanoate derivatives, optionally mono- or di-methylated at the carbon in the alpha position of propanoic acid, of formula (I), where R is CH3CH2CO—, (CH3)2CHCO— or (CH3)3CCO—, its hydroxy acid forms and the pharmaceutically acceptable salts of said hydroxy acids, as neuroprotective compounds potentially useful for the prevention and/or treatment of neurodegenerative diseases, or of diseases associated with an unwanted oxidation or of age-associated pathological processes, or of epilepsy, epileptic seizures or convulsions.
    Type: Application
    Filed: March 5, 2010
    Publication date: December 29, 2011
    Applicant: Parque Tecnologico de Ciencias de la Salud
    Inventors: Javier Santos Burgos Muñoz, Maria del Carmen Ramos Martín, Saleta Sierra Ávila, Juan María Alfaro Sánchez, Javier Velasco Alvarez, Ángel Rumbero Sánchez, Carlos Ramírez Moreno